Gilead renews IT contract with Cognizant in bid to more quickly bring drugs to market
Gilead is expanding and renewing an IT contract with Cognizant that is now worth up to $800 million over five years.
Cognizant said Monday that it is managing Gilead’s IT infrastructure and working on the company’s “digital transformation.” The IT and consulting company said streamlining parts of Gilead’s business may help bring drugs to market faster.
The companies first inked a partnership three years ago.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.